Most women with acne along the chin and jawline do NOT need hormone testing before starting treatment. Hormonal acne is diagnosed clinically, from history and presentation, not from a blood panel. Testing genuinely matters when there are accompanying signs of androgen excess — irregular periods, hirsutism, male-pattern hair loss, difficulty conceiving — because at that point you are no longer explaining the acne, you are screening for an endocrine condition behind it.
And if you do test, when the blood is drawn determines whether the result means anything: the wrong time of day, the wrong phase of the cycle, or being on the contraceptive pill can all produce a meaningless set of numbers.
This article answers exactly that part — the part most writing on hormonal acne skips. If you need to understand what hormonal acne is and how it differs from comedonal or inflammatory acne, read what acne is first; this piece starts where that one leaves off.
Written by the dermatology team at Eternal Beauty Center (An Hội Đông Ward, formerly Go Vap District, Ho Chi Minh City), drawing on DermNet NZ, the Journal of the Endocrine Society, the British Medical Journal and research indexed on PubMed/PMC.
1. Why the chin and jawline specifically
It is not coincidence that hormonal acne concentrates on the lower third of the face. Sebaceous glands across the chin, jawline, perioral area and upper neck carry a higher density of androgen receptors than elsewhere. At the same circulating hormone level, glands here respond more strongly — more sebum, thicker keratinisation at the follicular opening, and consequently deeper inflammation.
That explains three clinical features that tend to travel together:
Deep lesions, tender and swollen, rarely with an obvious extractable core — quite unlike blackheads or closed comedones on the forehead.
Few but persistent, each episode lasting weeks and recurring in the same spots.
More likely to leave marks and scars, because the inflammation is deep and prolonged — see post-acne dark marks.
One point worth stating clearly: "hormonal acne" does not mean your hormones are abnormal. In the vast majority of cases, hormone levels are entirely normal — the issue is receptor sensitivity in the skin, not the amount of hormone in the blood. This is the foundation for sections 3 and 5.
2. Recognised by signs, not by tests
Hormonal acne is a clinical diagnosis. Clinicians weigh the following, and the more that stack up, the likelier it is:
| Sign | Why it matters |
|---|---|
| Distribution on the lower third of the face — chin, jawline, perioral area, upper neck | The most androgen-sensitive sebaceous territory |
| Flares 7–10 days before menstruation | Luteal phase, shifting hormone ratios |
| Onset or persistence after age 25 | Adult female acne |
| Deep inflammatory lesions, few comedones | Characteristic of this group |
| Poor response to topicals alone despite months of correct use | The mechanism sits below what topicals reach |
| Clear worsening with stress or poor sleep | Disruption of the hormonal axis |
If three or more apply, that is good reason to see a dermatologist — not to go straight for a blood test, but to be assessed and matched to the right treatment direction.
3. So do you need testing? Two schools of thought
This is a point on which the literature genuinely disagrees, and you deserve to know that rather than be handed an absolute answer.
The first view — routine dermatology practice. No testing as standard. Adult female acne, including jawline acne that flares with the cycle, can be treated perfectly well without knowing androgen levels, because most results come back normal and would not change the plan. Testing is reserved for cases with signs suggesting androgen excess.
The second view — endocrine specialists. The multidisciplinary Androgen Excess and PCOS Society committee recommends measuring blood androgens in all women with adult acne — specifically total testosterone, free testosterone and DHEAS — arguing that persistent adult acne can be an early, and sometimes the only, sign of undiagnosed androgen excess.
Reconciling the two in practice:
If the goal is treating the acne, testing rarely changes the initial choice.
If the goal is not missing an underlying condition, the threshold for testing should be lower — particularly with any of the signs below.
Signs that make testing non-optional
When acne comes with any of the following, testing stops being discretionary:
Infrequent or absent periods (cycles longer than 35 days, or fewer than 8 per year)
Hirsutism — male-pattern hair on the face, chest or lower abdomen
Male-pattern hair loss — thinning at the crown, receding hairline
Difficulty conceiving
Polycystic ovaries on ultrasound
Rapid central weight gain, or acanthosis nigricans at the neck or underarms
Sudden, severe adult-onset acne, or clitoromegaly — this group needs rarer and more urgent causes excluded
4. If you test: which tests, and when
Timing matters as much as test selection. Drawn at the wrong moment, the result is uninterpretable — and you repeat it.
The panel usually considered
| Test | What it indicates |
|---|---|
| Total and free testosterone | The main androgens from ovaries and adrenals |
| DHEAS | Androgen of adrenal origin |
| LH/FSH ratio | Supports orientation toward polycystic ovary syndrome |
| 17-hydroxyprogesterone | Screens for late-onset congenital adrenal hyperplasia |
Depending on context, prolactin, thyroid function or glucose–insulin studies may be added.
Three conditions that decide whether the result is usable
One — draw in the morning, roughly 8–10am. Androgens follow a diurnal rhythm and peak in the morning; an afternoon draw can read falsely low.
Two — draw in the first half of the cycle, during menstruation or about a week before, to avoid landing near ovulation.
Three — stop combined oral contraceptives at least 6 weeks beforehand. The pill lowers androgens and masks abnormalities; testing while taking it will almost always look normal, even when something real is present.
A very common practical consequence: people get tested while taking the pill for their acne, receive a "normal" result, and conclude their acne isn't hormonal. That conclusion has no basis — the medication itself confounded the panel.
5. Do normal results rule out hormonal acne?
No. This is the single most common misunderstanding on the topic.
Return to the mechanism from section 1: in most women, hormonal acne is not caused by excess hormone but by sebaceous glands on the chin and jawline being unusually sensitive to normal hormone levels. Blood cannot measure receptor sensitivity in tissue — only circulating concentration.
So:
A normal panel remains entirely compatible with a diagnosis of hormonal acne, and does not rule out using hormonal therapy to treat it.
Anti-androgen treatment at the skin can still work even when blood androgens are not elevated.
The real value of a normal result is that it excludes an underlying condition — which is what it was for.
Put differently: the test answers "is there an endocrine condition behind this", not "is my acne hormonal".
6. Treatment: setting the right expectations about time
This group improves far more slowly than people expect — and giving up early is the most common reason treatment fails.
Options weighed case by case include foundational topicals, short-course oral antibiotics, hormonal therapy for women (combined oral contraceptives, anti-androgens), and isotretinoin for severe disease — the full treatment ladder is covered in what acne is.
What this article adds is the data on timing. The SAFA trial — a randomised, double-blind, placebo-controlled study in adult women with acne, published in the British Medical Journal in 2023 — used an escalating dose and followed participants to 24 weeks. The notable finding: improvement at week 24 was markedly greater than at week 12.
Which means:
Three months is the minimum assessment point, not the conclusion point. Courses longer than three months deliver more benefit than shorter ones.
Switching treatment every four to six weeks because "nothing is happening" is the surest way never to learn what works.
Side effects in the trial were acceptable; the clearest differences versus placebo were headache (20% vs 12%) and lightheadedness (19% vs 12%).
Essential caveat: every medication mentioned is prescription-only, requiring a doctor to prescribe and monitor. Some are contraindicated in pregnancy. Don't borrow someone else's prescription — the same-looking acne with a different history calls for a different plan.
Medical disclaimer: this article is educational and does not replace a consultation. Prescriptions and investigations require a doctor assessing you directly.
7. What skincare can and can't do here
Skincare does not address the cause of hormonal acne, but it largely determines whether you can tolerate the treatment that does.
What skincare can do:
Keep the skin barrier healthy enough to tolerate retinoids and other topicals — the most common reason people abandon treatment midway. See the skin barrier guide.
Reduce post-inflammatory marks through consistent sun protection and appropriate actives.
Avoid making things worse: no squeezing deep inflammatory lesions, no stacking multiple exfoliating actives — see the skincare actives guide.
What it cannot do: change the androgen sensitivity of sebaceous glands. No topical achieves that. Any product advertising that it "cures hormonal acne at the root" is claiming more than its mechanism allows.
8. How this is approached at Eternal
For persistent adult chin-and-jawline acne, the first job is not choosing a treatment but establishing whether this is hormonal acne and whether anything warrants an endocrine referral.
What that looks like:
Skin imaging and history — lesion distribution, relationship to the cycle, treatment history, current medication. See what skin analysis shows.
Screening for signs of androgen excess per the list in section 3; where present, referring to endocrinology rather than keeping the case as a purely cutaneous problem.
A combined protocol — medical acne treatment pairing prescribed medication with supporting interventions such as medical-grade extraction where appropriate.
Expectations set against real milestones — assessed at week 12, not concluded at week 4.
Frequently asked questions
Does hormonal acne resolve with age? There is no age that guarantees it. Hormonal acne in women often persists past 30, and in some cases into perimenopause. Waiting for it to "burn out" usually costs more marks and scarring, because these lesions sit deep.
What does testing cost, and do I need to fast? Cost depends on the facility and how many analytes are ordered. As for preparation, more important than fasting is the right time (8–10am), the right cycle phase (first half), and being off the contraceptive pill for at least six weeks. Ask the ordering doctor for specifics before the draw.
My chin breaks out but my periods are regular — do I need testing? Usually not, to begin treatment. Regular cycles are a meaningfully reassuring sign. With none of the features in section 3, you can be treated on clinical grounds and test only if response is unexpectedly poor or new signs appear.
Can I take the contraceptive pill for acne? Combined oral contraceptives are one of the evidence-backed hormonal therapies for acne in women, but must be prescribed — there are real contraindications involving clot risk, blood pressure, smoking and migraine history. This is not something to start on the strength of online advice.
Does diet improve hormonal acne? The clearest current evidence concerns high-glycaemic-index foods. Dietary adjustment can help, but it does not replace treatment for deep inflammatory acne. Treat it as an additional factor, not the main lever.
Why does my acne flare right before my period? During the luteal phase — roughly 7–10 days before menstruation — the ratio between hormones shifts and androgenic effect on sebaceous glands becomes relatively more dominant. On skin already androgen-sensitive, like the chin and jawline, that is enough to start a fresh inflammatory episode.
Six weeks of treatment and no improvement — should I switch? Usually not yet. SAFA trial data showed improvement at week 24 exceeding week 12 — meaning this group is measured in months. Discuss it with your doctor rather than stopping on your own: switching too early means never identifying what actually worked.
Key takeaways
Hormonal acne concentrates on the chin, jawline and perioral area because sebaceous glands there carry higher androgen receptor density.
In most women, hormone levels are normal — the issue is receptor sensitivity in the skin.
Most people don't need testing to start treatment. Testing exists to screen for an underlying condition, not to confirm whether acne is "hormonal".
Testing is non-optional with infrequent periods, hirsutism, male-pattern hair loss, difficulty conceiving, polycystic ovaries, or sudden severe adult-onset acne.
If testing: 8–10am · first half of the cycle · off the pill for at least 6 weeks — miss one and the result is uninterpretable.
Normal results do not rule out hormonal acne, nor rule out hormonal therapy.
Assess at week 12, not week 4 — SAFA showed week-24 improvement exceeding week 12.
Book a skin assessment with a dermatologist
If you have persistent deep inflammatory acne along the chin and jawline, the sensible step is a proper assessment before trying more products. A consultation with dermatologist Dr. Lê Hiền includes skin imaging, acne classification and grading, screening for signs that warrant endocrine referral, and a plan with clear assessment milestones.
Hotline / Zalo: 0334 713 610
Address: Eternal Beauty Center — An Hội Đông Ward (formerly Go Vap District), Ho Chi Minh City
Related treatments: E-Acne — medical acne treatment · O2 Peel — medical-grade extraction
References
DermNet NZ — Investigations in acne; Acne in adult women
Journal of the Endocrine Society — Female Adult Acne and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee
British Medical Journal (2023) — Effectiveness of spironolactone for women with acne vulgaris (SAFA): pragmatic, multicentre, phase 3, double blind, randomised controlled trial
British Journal of Dermatology — SAFA trial: a critically appraised topic
American Academy of Dermatology — guidelines for the management of acne vulgaris
Medscape / eMedicine — Acne Vulgaris Workup: Laboratory Studies
This article is educational and does not replace medical diagnosis or treatment. Every medication named is prescription-only and requires a doctor to prescribe and monitor.
